PubRank

J Kurtzberg

Author PubWeight™ 127.71‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998 7.07
2 Unintended changes in cognition, mood, and behavior arising from cell-based interventions for neurological conditions: ethical challenges. Am J Bioeth 2009 6.13
3 Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001 5.14
4 Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma. Proc Natl Acad Sci U S A 1989 2.45
5 A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood 1993 2.29
6 Chromosomal translocation in a human leukemic stem-cell line disrupts the T-cell antigen receptor delta-chain diversity region and results in a previously unreported fusion transcript. Proc Natl Acad Sci U S A 1989 2.23
7 Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant 2001 2.10
8 Ethical aspects of banking placental blood for transplantation. JAMA 1995 2.07
9 Successful therapy for trilateral retinoblastoma. Am J Ophthalmol 1992 2.03
10 Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group. Blood 1998 1.95
11 Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study. Leukemia 1999 1.89
12 Cord Blood Transplantation Study (COBLT): cord blood bank standard operating procedures. J Hematother 1998 1.82
13 Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase. N Engl J Med 1987 1.75
14 Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. N Engl J Med 1988 1.67
15 Early events in human T cell ontogeny. Phenotypic characterization and immunohistologic localization of T cell precursors in early human fetal tissues. J Exp Med 1988 1.62
16 High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. J Clin Oncol 1993 1.61
17 Cell-based interventions for neurologic conditions: ethical challenges for early human trials. Neurology 2008 1.57
18 Establishment of the DU.528 human lymphohemopoietic stem cell line. J Exp Med 1985 1.56
19 Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. Blood 2000 1.51
20 Umbilical cord blood hematopoietic stem and repopulating cells in human clinical transplantation. Blood Cells 1991 1.50
21 Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy. N Engl J Med 1998 1.47
22 Conversion of a stem cell leukemia from a T-lymphoid to a myeloid phenotype induced by the adenosine deaminase inhibitor 2'-deoxycoformycin. Proc Natl Acad Sci U S A 1984 1.46
23 Combination treatment of bullous pemphigoid with anti-CD20 and anti-CD25 antibodies in a patient with chronic graft-versus-host disease. Bone Marrow Transplant 2002 1.44
24 Evidence for susceptibility of intrathymic T-cell precursors and their progeny carrying T-cell antigen receptor phenotypes TCR alpha beta + and TCR gamma delta + to human immunodeficiency virus infection: a mechanism for CD4+ (T4) lymphocyte depletion. Proc Natl Acad Sci U S A 1990 1.43
25 Human herpesvirus 6 limbic encephalitis after stem cell transplantation. Ann Neurol 2001 1.43
26 Umbilical cord blood stem cells: application for the treatment of patients with hemoglobinopathies. J Pediatr 1997 1.42
27 Ontogeny of T-cell precursors: a model for the initial stages of human T-cell development. Immunol Today 1989 1.41
28 T-Cell recovery in adults and children following umbilical cord blood transplantation. Biol Blood Marrow Transplant 2001 1.33
29 Phenotypic and genotypic analysis of a human medulloblastoma cell line and transplantable xenograft (D341 Med) demonstrating amplification of c-myc. Am J Pathol 1988 1.23
30 Evaluation of white matter anisotropy in Krabbe disease with diffusion tensor MR imaging: initial experience. Radiology 2001 1.23
31 Diffusion tensor imaging detects abnormalities in the corticospinal tracts of neonates with infantile Krabbe disease. AJNR Am J Neuroradiol 2009 1.18
32 Phase I trial and pharmacokinetic (PK) and pharmacodynamics (PD) study of topotecan using a five-day course in children with refractory solid tumors: a pediatric oncology group study. J Pediatr Hematol Oncol 1996 1.18
33 Severe Mycoplasma pneumonia in three sisters with sickle cell disease. Pediatr Hematol Oncol 1986 1.16
34 High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors. J Clin Oncol 1997 1.14
35 Paradoxical expression of adenosine deaminase in T cells cultured from a patient with adenosine deaminase deficiency and combine immunodeficiency. J Clin Invest 1990 1.12
36 Isolation of early hematopoietic cells, including megakaryocyte progenitors, in the ALDH-bright cell population of cryopreserved, banked UC blood. Cytotherapy 2007 1.10
37 Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients. Biol Blood Marrow Transplant 2001 1.08
38 Emerging trends in transplantation of inherited metabolic diseases. Bone Marrow Transplant 2008 1.07
39 Central nervous system atypical teratoid tumor/rhabdoid tumor: response to intensive therapy and review of the literature. J Neurooncol 1998 1.07
40 Human thymic epithelial cells directly induce activation of autologous immature thymocytes. Proc Natl Acad Sci U S A 1988 1.06
41 Compound GW506U78 in refractory hematologic malignancies: relationship between cellular pharmacokinetics and clinical response. J Clin Oncol 1998 1.06
42 Human umbilical cord blood: a clinically useful source of transplantable hematopoietic stem/progenitor cells. Int J Cell Cloning 1990 1.05
43 Associations between antibiotic exposure during pregnancy, birth weight and aberrant methylation at imprinted genes among offspring. Int J Obes (Lond) 2013 1.05
44 Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment. Bone Marrow Transplant 2013 1.04
45 Pharmacokinetics of nelarabine and 9-beta-D-arabinofuranosyl guanine in pediatric and adult patients during a phase I study of nelarabine for the treatment of refractory hematologic malignancies. J Clin Oncol 2000 1.02
46 Hematopoietic cell transplantation for Chediak-Higashi syndrome. Bone Marrow Transplant 2007 1.02
47 The effects of depression and use of antidepressive medicines during pregnancy on the methylation status of the IGF2 imprinted control regions in the offspring. Clin Epigenetics 2011 1.00
48 Immunoglobulin and T-cell receptor gene rearrangement and expression in human lymphoid leukemia cells at different stages of maturation. Proc Natl Acad Sci U S A 1986 0.99
49 Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy. Blood 1993 0.99
50 Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type 1b. Blood 2001 0.99
51 Human thymic epithelial cells produce granulocyte and macrophage colony-stimulating factors. J Immunol 1988 0.98
52 Human postnatal CD4- CD8- CD3- thymic T cell precursors differentiate in vitro into T cell receptor delta-bearing cells. J Immunol 1989 0.95
53 Rescuing the neonatal brain from hypoxic injury with autologous cord blood. Bone Marrow Transplant 2012 0.93
54 Chronic immune-mediated thrombocytopenia after varicella infection. J Pediatr 1988 0.93
55 Determinants of deoxyadenosine toxicity in hybrids between human T- and B- lymphoblasts as a model for the development of drug resistance in T-cell acute lymphoblastic leukemia. Cancer Res 1985 0.92
56 Umbilical cord blood transplantation for non-malignant diseases. Bone Marrow Transplant 2009 0.91
57 S-adenosylhomocysteine catabolism and basis for acquired resistance during treatment of T-cell acute lymphoblastic leukemia with 2'-deoxycoformycin alone and in combination with 9-beta-D-arabinofuranosyladenine. Cancer Res 1983 0.90
58 Umbilical cord blood: a novel alternative source of hematopoietic stem cells for bone marrow transplantation. J Hematother 1996 0.90
59 Human recombinant stem-cell factor induces melanocytic hyperplasia in susceptible patients. J Am Acad Dermatol 1995 0.89
60 An open-label, multicenter study of polyethylene glycol-L-asparaginase for the treatment of acute lymphoblastic leukemia. Cancer 1995 0.87
61 Disseminated histoplasmosis: a cause of infection-associated hemophagocytic syndrome. Am J Pediatr Hematol Oncol 1994 0.87
62 Multiparameter-fluorescence activated cell sorting analysis of retroviral vector gene transfer into primitive umbilical cord blood cells. Exp Hematol 1998 0.87
63 Isolation of oligodendrocyte-like cells from human umbilical cord blood. Cytotherapy 2008 0.86
64 The c-kit proto-oncogene receptor is expressed on a subset of human CD3-CD4-CD8- (triple-negative) thymocytes. Exp Hematol 1994 0.86
65 Swainsonine protects both murine and human haematopoietic systems from chemotherapeutic toxicity. Br J Cancer 1999 0.85
66 Studies of human bone marrow treated with soybean lectin and sheep erythrocytes: stepwise analysis of cell morphology, phenotype and function. Clin Exp Immunol 1987 0.85
67 Association of reticular dysgenesis (thymic alymphoplasia and congenital aleukocytosis) with bilateral sensorineural deafness. J Pediatr 1999 0.84
68 Management of leukemic hyperleukocytosis with hydration, urinary alkalinization, and allopurinol. Are cranial irradiation and invasive cytoreduction necessary? Am J Pediatr Hematol Oncol 1993 0.83
69 Activity of high-dose cyclophosphamide in the treatment of childhood malignant gliomas. Med Pediatr Oncol 1998 0.83
70 Childhood hepatic mesenchymoma: successful treatment with surgery and multiple-agent chemotherapy. Med Pediatr Oncol 1988 0.83
71 Modulation of macrophage colony stimulating factor in cultured human retinal pigment epithelial cells. Exp Eye Res 1992 0.82
72 Efficacy and toxicity of 9-beta-D-arabinofuranosylguanine (araG) as an agent to purge malignant T cells from murine bone marrow: application to an in vivo T-leukemia model. Leukemia 1993 0.82
73 Allogeneic hematopoietic SCT for alpha-mannosidosis: an analysis of 17 patients. Bone Marrow Transplant 2011 0.82
74 Melphalan transport, glutathione levels, and glutathione-S-transferase activity in human medulloblastoma. Cancer Res 1988 0.82
75 The coenrichment of stem cells, prothymocytes, and stromal elements with ecotropic retrovirus-producing cells from the bone marrow of leukemia-prone AKR mice. Virology 1988 0.81
76 Graft-versus-leukemia-induced complete remission following unrelated umbilical cord blood transplantation for acute leukemia. Bone Marrow Transplant 2000 0.80
77 Pharmacologic purging of malignant T cells from human bone marrow using 9-beta-D-arabinofuranosylguanine. Transplantation 1991 0.80
78 Evaluation of synergy between carbovir and 3'-azido-2',3'-deoxythymidine for inhibition of human immunodeficiency virus type 1. Antimicrob Agents Chemother 1993 0.80
79 Globoid cell leukodystrophy (Krabbe disease): normal umbilical cord blood galactocerebrosidase activity and polymorphic mutations. J Inherit Metab Dis 2005 0.79
80 Pulmonary septic emboli mimicking metastatic rhabdomyosarcoma. J Pediatr Surg 1989 0.79
81 Toxicity, pharmacology and feasibility of administration of PEG-L-asparaginase as consolidation therapy in patients undergoing bone marrow transplantation for acute lymphoblastic leukemia. Bone Marrow Transplant 1998 0.79
82 A phase I trial of recombinant human interleukin-1 beta (OCT-43) following high-dose chemotherapy and autologous bone marrow transplantation. Bone Marrow Transplant 1997 0.79
83 Treatment of lymphohistiocytic erythrophagocytosis with VP-16 and aziridinylbenzoquinone. Med Pediatr Oncol 1987 0.78
84 Successful treatment of two children with Langerhans' cell histiocytosis with 2'-deoxycoformycin. J Pediatr Hematol Oncol 1996 0.78
85 Measurements from normal umbilical cord blood of four lysosomal enzymatic activities: alpha-L-iduronidase (Hurler), galactocerebrosidase (globoid cell leukodystrophy), arylsulfatase A (metachromatic leukodystrophy), arylsulfatase B (Maroteaux-Lamy). Bone Marrow Transplant 2000 0.78
86 Dose escalation trial of cyclophosphamide with Sargramostim in the treatment of central nervous system (CNS) neoplasms. Med Pediatr Oncol 1995 0.78
87 9p- in a girl with acute lymphocytic leukemia and sickle cell disease. Cancer Genet Cytogenet 1986 0.78
88 Reversal of radiation-induced neutropenia by granulocyte colony-stimulating factor. Med Pediatr Oncol 1992 0.78
89 Management of cholelithiasis in pediatric patients who undergo bone marrow transplantation. J Pediatr Surg 2001 0.78
90 Hematologic engraftment and reconstitution of immune function post unrelated placental cord blood transplant in an adult with acute lymphocytic leukemia. Leuk Res 1998 0.78
91 Extensive haplotype diversity in African American mothers and their cord blood units. Tissue Antigens 2012 0.77
92 Effects of granulocyte-macrophage colony stimulating factor produced in Chinese hamster ovary cells (regramostim), Escherichia coli (molgramostim) and yeast (sargramostim) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy. Eur J Haematol 1995 0.77
93 Cord blood stem cells. Curr Opin Hematol 1997 0.77
94 Treatment of patients with pineoblastoma with high dose cyclophosphamide. Med Pediatr Oncol 1996 0.77
95 Isolation and characterization of the genomic human CD7 gene: structural similarity with the murine Thy-1 gene. Proc Natl Acad Sci U S A 1991 0.77
96 Treatment of trilateral retinoblastoma with vincristine and cyclophosphamide. Am J Ophthalmol 1986 0.76
97 Alloimmune thrombocytopenia may be associated with systemic disease. Am J Obstet Gynecol 1992 0.76
98 Banking and transplantation of unrelated donor umbilical cord blood: status of the National Heart, Lung, and Blood Institute-sponsored trial. Transfusion 1998 0.76
99 Cisplatinum-induced renal salt wasting. Med Pediatr Oncol 1984 0.76
100 Accidental heparinization in the newborn: a case report and brief review of the literature. J Perinatol 1990 0.76
101 Successful treatment of childhood pilocytic astrocytomas metastatic to the leptomeninges with high-dose cyclophosphamide. Med Pediatr Oncol 1996 0.76
102 Collaborative multicenter investigation of marrow transplantation for sickle cell disease: current results and future directions. Biol Blood Marrow Transplant 1997 0.76
103 Complete hematologic and cytogenetic response to 2-amino-9-beta-D-arabinosyl-6-methoxy-9H-guanine in a patient with chronic myelogenous leukemia in T-cell blastic phase: a case report and review of the literature. Cancer 1999 0.75
104 Transplantation of cord-blood cells. N Engl J Med 1995 0.75
105 In reply. Transfusion 2014 0.75
106 Development of a model of melphalan-induced gastrointestinal toxicity in mice. Cancer Chemother Pharmacol 1993 0.75
107 Effects of granulocyte-macrophage colony stimulating factor produced in Chinese hamster ovary cells (regramostim), Escherichia coli (molgramostim) and yeast (sargramostim) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy. Eur J Haematol 1995 0.75
108 Altered regulation of S-adenosylmethionine dependent methylation in adenosine deaminase deficiency. Prog Clin Biol Res 1985 0.75
109 Elimination of malignant clonogenic T cells from human bone marrow using chemoimmunoseparation with 2'-deoxycoformycin, deoxyadenosine and an immunotoxin. Bone Marrow Transplant 1990 0.75
110 Retroviral vector-mediated gene transfer into umbilical cord blood-derived megakaryocyte and platelet progenitors. Biol Blood Marrow Transplant 1999 0.75
111 High-dose intravenous immunoglobulin for severe platelet alloimmunization. Pediatrics 1984 0.75
112 A seven-month-old infant with fever and neutrophilic leukocytosis. J Pediatr 1992 0.75
113 Familial erythrophagocytic lymphohistiocytosis: late relapse despite continuous high-dose VP-16 chemotherapy. Med Pediatr Oncol 1990 0.75
114 Cyclophosphamide in combination with sargramostim for treatment of recurrent medulloblastoma. Med Pediatr Oncol 1995 0.75
115 Cerebrospinal fluid protein elevation secondary to a subdural fluid collection in a child receiving multiple lumbar punctures. J Pediatr 1989 0.75
116 Retinoblastoma metastatic to bone marrow. A case with florid spread. Clin Pediatr (Phila) 1984 0.75
117 Frequency of bone marrow aspirates in leukemia. J Pediatr 1984 0.75
118 Effects of cranial radiation in children with high risk T cell acute lymphoblastic leukemia: a Pediatric Oncology Group report. Leukemia 2000 0.75
119 Vincristine therapy for severe platelet alloimmunization. Am J Pediatr Hematol Oncol 1991 0.75
120 Unrelated placental blood in marrow transplantation. Stem Cells 2000 0.75
121 The use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous bone marrow transplantation. Prog Clin Biol Res 1990 0.75
122 The uses of intravenous immunoglobulin in pediatrics. An update. Crit Rev Oncol Hematol 1992 0.75
123 Combined chemoseparation and immunoseparation of clonogenic T lymphoma cells from human bone marrow using 2'-deoxycoformycin, deoxyadenosine, 3A1 monoclonal antibody, and complement. Cancer Res 1987 0.75
124 Role of cytokines in autologous bone marrow transplantation. Hematol Oncol Clin North Am 1993 0.75
125 Retroviral gene transduction of circulating progenitor cells in patients with metastatic breast cancer. Surg Oncol 1993 0.75
126 Modification of a commercial cell sorter to support efficient and reliable preparation of ALDH-bright cells for clinical use. Cytotherapy 2007 0.75
127 Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors: G-CSF, GM-CSF, IL-1, IL-2, M-CSF. Ann Hematol 1993 0.75
128 Criteria for termination of phase II chemotherapy for patients with progressive or recurrent brain tumor. Neurology 1989 0.75
129 Abnormalities in S-adenosylhomocysteine hydrolysis, ATP catabolism, and lymphoid differentiation in adenosine deaminase deficiency. Ann N Y Acad Sci 1985 0.75
130 Congenital Pelger-Huet anomaly in triplets. Am J Hematol 1988 0.75
131 Elimination of clonogenic malignant human T cells using monoclonal antibodies in combination with 2'-deoxycoformycin. J Clin Oncol 1987 0.75
132 Papillary adenocarcinoma of the renal pelvis in a child: case report and brief review of the literature. Med Pediatr Oncol 1990 0.75